La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Dopamine Plasma Membrane Transport Proteins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine D4 receptors < Dopamine Plasma Membrane Transport Proteins < Dopamine Plasma Membrane Transport Proteins (antagonists & inhibitors)  Facettes :

List of bibliographic references indexed by Dopamine Plasma Membrane Transport Proteins

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
002953 (2005) Wonsuk Yang [États-Unis] ; Evelyn Tiffany-CastiglioniThe bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis.
002968 (2005) Wing Lok Au [Canada] ; John R. Adams ; André R. Troiano ; A Jon StoesslParkinson's disease: in vivo assessment of disease progression using positron emission tomography.
002D75 (2003) Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
002D76 (2003) Iometopane: (123)I beta-CIT, dopascan injection, GPI 200, RTI 55.
002D86 (2003) A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
002E06 (2003) Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]Age and severity of nigrostriatal damage at onset of Parkinson's disease
002F78 (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
003032 (2002) Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
003237 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
003308 (2001) M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada]Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
003363 (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
003440 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
003485 (2000) Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
003513 (2000) J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
003618 (1999) D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. IchiseExternal radioactive reference markers in SPECT imaging of the dopamine system.
003800 (1999) M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada]SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD
003822 (1999) M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. LangFunctional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data
003A60 (1997) M. Guttman [Canada] ; J. Burkholder ; S J Kish ; D. Hussey ; A. Wilson ; J. Dasilva ; S. Houle[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.
004813 (1991) H. B. Niznik ; E. F. Fogel ; F. F. Fassos ; P. SeemanThe dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus
004855 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Plasma Membrane Transport Proteins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Plasma Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Plasma Membrane Transport Proteins
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022